Search Within

Vidushi Durani

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (8)
  4. Human Oncology and Pathogenesis Program (8)
  5. Sloan Kettering Institute Postdocs (8)
  6. Department of Pathology and Laboratory Medicine (7)

More Groups

People
  1. Alvaro Quintanal Villalonga (4)
  2. Amin Sabet (4)
  3. Charles Rudin (4)
  4. Ester Redin Resano (4)
  5. Harsha Sridhar (4)
  6. Kenta Kawasaki (4)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (1)
Publications
  1. Blood (1)
  2. Blood Advances (1)
  3. Cancer Discovery (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Thoracic Oncology (1)
  6. Nature (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. American Association for the Advancement of Science (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of CDC7 inhibition and MYC degradation on neuroendocrine transformation in the lung and prostate cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Rakhade, S.; Durani, V.; Sabet, A.; Karthaus, W.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
    Journal Article

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Uddin, F.; Rakhade, S.; Durani, V.; Sabet, A.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; more...
    Signal Transduction and Targeted Therapy (2024)

    Fulltext@MSK | Save
  • Exportin 1 inhibition constraints lineage plasticity and histological transformation through downregulation of SOX2
    Meeting Abstract

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shaffer, M.; Manoj, P.; Sridhar, H.; Haffner, M. C.; Sawyers, C. L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
    Journal Article

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
    Journal Article

    Xiao, W.; Miles, L. A.; Bowman, R. L.; Durani, V.; Tian, H. S.; DelGaudio, N. L.; Mishra, T.; Zhu, M.; Zhang, Y.; Stump, S. E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition
    Journal Article

    Cai, S. F.; Chu, S. H.; Goldberg, A. D.; Parvin, S.; Koche, R. P.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
    Journal Article

    Intlekofer, A. M.; Shih, A. H.; Wang, B.; Nazir, A.; Rustenburg, A. S.; Albanese, S. K.; Patel, M.; Famulare, C.; Correa, F. M.; Takemoto, N.; more...
    Nature (2018)

    Fulltext@MSK | Save